Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant

NCT03622788 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Aplastic Anemia
Bone Marrow Failure
Chronic Lymphocytic Leukemia
Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Myelodysplastic Syndrome
Myeloproliferative Neoplasm
Non-Hodgkin Lymphoma
Plasma Cell Myeloma

Interventions

BIOLOGICAL: Anti-Thymocyte Globulin
DRUG: Cyclophosphamide
BIOLOGICAL: Cytokine-treated Veto Cells
DRUG: Fludarabine
PROCEDURE: Peripheral Blood Stem Cell Transplantation
RADIATION: Total-Body Irradiation

Sponsor

M.D. Anderson Cancer Center